Skip to main content

Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical study

Summary

In this paper we present the results of a 12-month double-blind clinical multicenter study assessing the effects of synthetic salmon cacitonin (CT) administration in a group of white postmenopausal osteoporotic women. Treated patients were given 100 MRC units of synthetic salmon CT injected i.m. in the morning every other day. Control patients received a placebo injection. All patients received 500 mg of elementary calcium p.o., b.i.d. Bone mineral content (BMC) was measured at the extreme distal radius of the nondominant arm by a dual photon bone densitometer which utilizes two radionuclides,241Am and125I, with energies of about 60 keV and 30 keV respectively. Biochemical parameters of calcium-phosphorus metabolism were also measured. After 12 months of treatment a significant mean increment of BMC and nondialyzable OHPr/creatinine values and a significant decrease of total OHPr/creatinine values were observed in the treated group, while controls showed a significant decrease in BMC values. These results, together with the observation that in some patients the decrease in total OHPr/creatinine values was not accompanied by an increment of BMC, show that long-term salmon CT treatment may be of benefit in postmenopausal osteoporosis and that the effects of CT on bone mass may be due not only to the inhibition of bone resorption but also to the stimulation of bone formation.

This is a preview of subscription content, access via your institution.

References

  1. Milhaud G, Talbot JN, Coutris G (1975) Calcitonin treatment of postmenopausal osteoporosis. Evaluation of efficacy by principal components analysis. Biomedicine 22:223–232

    PubMed  CAS  Google Scholar 

  2. Wallach S, Cohn SH, Atkins HL, Ellis KJ, Kohberger R, Aloia JF, Zanzi I (1977) Effects of salmon calcitonin on skeletal mass in osteoporosis. Curr Therapeutic Res 22:556–572

    Google Scholar 

  3. Cohn SH, Dombrowski CS, Hauser W, Klopper J, Atkins HL (1971) Effects of porcine calcitonin in osteoporosis. J Clin Endocrinol Met 33: 719–728

    CAS  Article  Google Scholar 

  4. Jowsey J, Riggs BL, Kelly PJ, Hoffman DL (1978) Calcium and salmon calcitonin in treatment of osteoporosis. J Clin Endocrinol Met 47:633–639

    CAS  Google Scholar 

  5. Gruber HE, Ivey JL, Baylink DJ, Matthews M, Nelp WB, Sisom K, Chesnut III CH (1984) Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33: 295–303

    PubMed  Article  CAS  Google Scholar 

  6. Hodgkinson A, Knowles CF (1967) Laboratory Methods. In: Nordin BEC (ed) Calcium, phosphate and magnesium metabolism. Churchill-Livingstone, London, pp 525–564

    Google Scholar 

  7. Krane SM, Munoz AS, Harris ED (1970) Urinary polypeptides related to collagen synthesis. J Clin Invest 49: 716–729

    PubMed  CAS  Article  Google Scholar 

  8. Agrawal R, Wallach S, Cohn S, Tessier M, Verch R, Hussain M, Zanzi I (1981) Calcitonin treatment of osteoporosis. In: Pecile A (ed) Calcitonin 1980: chemistry, physiology, pharmacology and clinical aspects. Excerpta Medica, Amsterdam, pp 237–246

    Google Scholar 

  9. Christiansen C, Rodbro P (1975) Estimation of total body calcium from the bone mineral content of the forearm. Scand J Clin Lab Invest 35:425–431

    PubMed  CAS  Google Scholar 

  10. Mazess BR (1983) The noninvasive measurement of skeletal mass. In: Peck WA (ed) Bone and mineral research. Annual 1, Excerpta Medica, Amsterdam, pp 223–279

    Google Scholar 

  11. Horsman A, Burkinshaw L, Pearson D, Oxby CB, Milner RM (1983) Estimating total body calcium from peripheral bone measurements. Calcif Tissue Int 35:135–144

    PubMed  Article  CAS  Google Scholar 

  12. Awbrey BJ, Jacobson PC, Grubb SA, McCartney WH, Vincent LM, Talmage RV (1984) Bone density in women: a modified procedure for measurement of distal radial density. J Orthop Res 2: 292–295

    Article  Google Scholar 

  13. Krolner B, Pors Nilsen S, Jacobsen S (1982) Lumbar spine bone mineral content and osteoporosis. In: Menczel J, Robin GC, Makin M, Steimberg R (eds) Osteoporosis. J Wiley and Sons Ltd., New York, pp 87–90

    Google Scholar 

  14. Orimo H (1984) Recent advances in the treatment of senile osteoporosis. In: Cohn DV, Potts JT Jr, Fujita T (eds) Endocrine control of bone and calcium metabolism. Elsevier Science Publishers, Amsterdam, pp 292–295

    Google Scholar 

  15. Caniggia A, Gennari C, Bencini M, Cesari L, Borrello G (1970) Calcium metabolism and 47 calcium kinetics before and after long-term thyrocalcitonin treatment in senile osteoporosis. Clin Sci 38:397–407

    CAS  Google Scholar 

  16. Chesnut III CH, Baylink DJ, Gruber HE, Ivey JL, Matthews M, Sisom K, Nelp WB (1981) Treatment of postmenopausal osteoporosis with salmon calcitonin: preliminary results. In: De Luca HF, Frost HM, Jee WSS, Johnston CC Jr, Parfitt AM (eds) Osteoporosis. University Park Press, Baltimore, pp 411–418

    Google Scholar 

  17. Chesnut III CH, Baylink DJ, Roos BA, Gruber HE, Ivey JL, Matthews M, Nelp WB, Sisom K (1981) Calcitonin and postmenopausal osteoporosis In: Pecile A (ed) Calcitonin 1980, chemistry, physiology, pharmacology and clinical aspects, Excerpta Medica, Amsterdam, pp 247–255

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The results of this study were partially reported in an abstract presented at the International Symposium “Calcitonin '84”, held in Milan on 2–4 October 1984.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mazzuoli, G.F., Passeri, M., Gennari, C. et al. Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical study. Calcif Tissue Int 38, 3–8 (1986). https://doi.org/10.1007/BF02556587

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02556587

Key words

  • Postmenopausal osteoporosis
  • Calcitonin
  • Bone mineral content